MP:0001805 | decreased IgG | "less than normal immunoglobulin class G level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
|
MP:0001876 | decreased inflammatory response | "less than expected response to injury, infection, or insult" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|
MP:0002359 | abnormal spleen germinal center morphology | "anomalous structure or formation of the area of the spleen in which activated follicles are located" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Pathology:ISBN 0-397-51047-0] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
|
MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
|
MP:0005087 | reduced acute inflammation | "less than the expected early reaction of the microcirculation, characterized by movement of fluid and leukocytes from the blood into extravascular tissues; initiated by injury, infection, or local immune response " [Pathology:ISBN 0-397-51047-0, J:74478] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
Allelic Composition: Traddtm1.1Mak/Tradd+ Genetic Background: either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N)
|
MP:0008473 | abnormal spleen follicular dendritic cell network | "any structural anomaly of the enmeshed group of antigen presenting cells with extensive dendritic processes in the spleen B cell follicle that present antigen to B cells during an immune response" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|
MP:0008474 | absent spleen germinal center | "absence of the area of the spleen secondary B follicle where rapid B-cell proliferation, somatic hypermutation, and selection for antigen binding occurs" [PMID:17495967] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|
MP:0008554 | decreased circulating tumor necrosis factor level | "reduction in the amount in the blood of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Traddtm1.1Mpa/Traddtm1.1Mpa Genetic Background: involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Pcntm239Asp/Pcnt+,Tg(mI56i-lacZ)1Mekk/0 Genetic Background: involves: C57BL/6J * FVB/N
|
MP:0008597 | decreased circulating interleukin-6 level | "reduction in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|
MP:0008706 | decreased interleukin-6 secretion | "reduction in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|
MP:0008751 | abnormal interleukin level | "deviation from the normal levels of soluble factors which stimulate growth-related activities of leukocytes as well as other cell types; they enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli" [MESH:D12.644.276.374.465] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
|
MP:0008874 | decreased sensitivity to xenobiotics | "increase in the dose or concentration of a foreign compound required to induce a specific level of response" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Glipr1tm1Tt/Glipr1tm1Tt,Trp53tm1Brd/Trp53+ Genetic Background: involves: 129S7/SvEvBrd
Allelic Composition: Traddtm1.1Zgl/Traddtm1.1Zgl Genetic Background: involves: C57BL/6 * FVB/N
|
MP:0008944 | decreased sensitivity to induced cell death | "increase in the exposure level to an agent that is required to induce cessation of function at the cellular level" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Rgs5tm1.1Rgan/Rgs5tm1.1Rgan Genetic Background: involves: 129 * C57BL/6
|